DeprescribingNCT03233971
How do Older Adults and Caregivers Feel About Their Medications?
An observational study of Deprescribing, run by Monash University at 1 site in Singapore.
Trial summary
The aim of this study is to study patients' and caregivers' perspectives towards deprescribing using the Revised Patients' Attitudes Towards Deprescribing (rPATD) questionnaire. Read more about this study
- Who is it for?
- Ages 65 years and older
- Conditions the study is for
- Deprescribing
- What is being tested?
- rPATD Questionnaire
- How many people
- 1,057 participants
- Where
- 1 siteSingapore
- Study dates
- 25 Jul 2017to 30 Mar 2018
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 65 years and older
- All sexes
- Older adult
Study population: Potential participants will be selected by convenient sampling from walk-in patients/caregivers who present at the participating pharmacies seeking advice or medication.
Who may be able to join
- Older adults' inclusion criteria:
- age at least 65 years;
- taking one or more long-term prescription medication;
- have not participated in this anonymous questionnaire previously
- Caregivers' inclusion criteria:
- currently an informal caregiver for an older adult (defined as having any role in a family member or friend's management of health and/or medications);
- care recipient must be at least 65 years of age and taking one or more long-term prescription medication;
- have not participated in this anonymous questionnaire previously
Who cannot join
- Older adults' exclusion criteria:
- inability to complete a questionnaire in English.
- Caregivers' exclusion criteria:
- caregiver's age less than 21 years;
- caregiver's inability to complete a questionnaire in English.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Patients' and Caregivers' Attitudes Towards Deprescribing in the Asian Community Setting
The aim of this study is to study patients' and caregivers' perspectives towards deprescribing using the Revised Patients' Attitudes Towards Deprescribing (rPATD) questionnaire.
- Conditions
- Deprescribing
- Being tested
- rPATD Questionnaire
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
rPATD QuestionnaireOther
A 5-point Likert scale questionnaire consisting of 22 questions for older adults, and 19 questions of caregivers.
| Study group | Role | What they receive |
|---|---|---|
| Older adults | Not described Receives: Other: rPATD Questionnaire | |
| Caregivers | Not described Receives: Other: rPATD Questionnaire |
What is being measured
The primary outcome is the main question the study is designed to answer.
rPATD questionnaire scorings
Measured: up to 9 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted31 Jul 2017
- Study start25 Jul 2017
- Primary completion30 Mar 2018
- Study completion30 Mar 2018
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for DeprescribingStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Prospective
- Enrolment
- 1,057 participants (actual)
Sponsor and investigators
- Lead sponsor
- Monash University
- Sponsor type
- University, hospital or other
- Collaborators
- Guardian, NTUC Unity, Watsons, Kwong Wai Shiu Hospital, Ang Mo Kio - Thye Hua Kwan Hospital, Khoo Teck Puat Hospital, National University Hospital, Singapore, Singapore General Hospital, Tan Tock Seng Hospital, National Healthcare Group Pharmacy
- Responsible party
- Principal investigator, Kua Chong Han, Monash University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03233971
- Sponsor's protocol ID
- 2017-8872
- Status last verified
- Apr 2018
- First submitted
- 24 Jul 2017
- Last updated
- 4 Apr 2018
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 4 Apr 2018. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Patients' and Caregivers' Attitudes Towards Deprescribing in the Asian Community Setting
- ClinicalTrials.gov ID
- NCT03233971
- Acronym / sponsor ID
- 2017-8872
- Conditions
- Deprescribing
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 1,057 participants (actual)
- Lead sponsor
- Monash UniversityUniversity, hospital or other
- Collaborators
- Guardian, NTUC Unity, Watsons, Kwong Wai Shiu Hospital, Ang Mo Kio - Thye Hua Kwan Hospital, Khoo Teck Puat Hospital, National University Hospital, Singapore, Singapore General Hospital, Tan Tock Seng Hospital, National Healthcare Group Pharmacy
- Study start
- 25 Jul 2017 (actual)
- Primary completion
- 30 Mar 2018 (actual)
- Study completion
- 30 Mar 2018 (actual)
- First posted
- 31 Jul 2017 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of this study is to study patients' and caregivers' perspectives towards deprescribing using the Revised Patients' Attitudes Towards Deprescribing (rPATD) questionnaire.
Study design
- Observational model
- Other
- Time perspective
- Prospective
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Older adults | – | Other: rPATD Questionnaire |
| Caregivers | – | Other: rPATD Questionnaire |
Who may qualify
- Ages
- 65 years and older
- Sex
- All
- Age groups
- Older adult
- Study population
- Potential participants will be selected by convenient sampling from walk-in patients/caregivers who present at the participating pharmacies seeking advice or medication.
Key inclusion criteria (8 listed)
- Older adults' inclusion criteria:
- Caregivers' inclusion criteria:
Key exclusion criteria (5 listed)
- Older adults' exclusion criteria:
- Caregivers' exclusion criteria:
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| rPATD QuestionnaireA 5-point Likert scale questionnaire consisting of 22 questions for older adults, and 19 questions of caregivers. | Other | Caregivers, Older adults |
Primary outcome
rPATD questionnaire scorings
Time frame: up to 9 months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 4 Apr 2018.
- Individual participant dataSharing planned: No
Related trials for Deprescribing
Active, not recruiting
Health enSuite Insomnia: an App-based Treatment for Adult Chronic Insomnia
Insomnia
RecruitingObservational study
Informative Exhibition for Deprescribing Benzodiazepines
Benzodiazepine-Related Disorders
Active, not recruitingObservational study
Psychoactive Drug Use and Acute Care Use After Trauma and Out-of-Hospital Cardiac Arrest
Wounds and Injuries, Out-of-Hospital Cardiac Arrest
Enrolling by invitationPhase 4
Deprescribing Beta-Blockers in Elders With Heart Failure With Preserved Ejection Fraction (DEPRESCRIBE-HFpEF)
Heart Failure, HFpEF
Enrolling by invitation
Testing the Impact of Pre-visit Priming for Medications
Deprescribing, Statin Prescribing
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Deprescribing, run by Monash University at 1 site in Singapore.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 8 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 4 Apr 2018. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Singapore. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
rPATD questionnaire scorings (time frame: up to 9 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Apr 2018.